Skip to NavigationSkip to content

Pharmafile - Manufacturing and Production News

Researchers from KTH The Royal Institute of Technology and Gothenburg University have identified new drug targets in the treatment of liver cancer...
AstraZeneca and MedImmune, the company’s biologics research arm, have forged a five year research partnership with mRNA-based pulmonary disease...
Hikma, a generic drugmaker, has been revealed as planning an increase of 430% on its medicine for diarrhoea.
Ironwood Pharmaceuticals has announced that the FDA has approved its drug Duzallo for the treatment of hyperuricemia associated with gout in...
It has been revealed that private hospitals being run across England and Wales will receive £52 million in tax breaks over the course of the next...
Another Opdivo failure for BMS, "highly disturbing" stats on childhood diabetes, and Trump left red-faced as his 'America first' manufacturing policy...
Shire has announced that it has submitted its dry-eye drug, lifitegrast, for European marketing approval. The filing comes after it gained approval...
Gilead is set for the grand unveiling of its new facility in La Verne, Southern California, after several years of work. The facility, once it is...
Regeneron has announced that the failure of suptavumab, its experimental treatment for respiratory syncytial virus (RSV), in late-stage trials, the...
A small biotech that has been working on developing one treatment for the last decade has finally seen the fruits of their labour, with Mundipharma...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches